SCYNEXIS, Inc. to Present at the 15th Annual Needham Healthcare Conference

JERSEY CITY, N.J., April 06, 2016 (GLOBE NEWSWIRE) -- Drug development company SCYNEXIS, Inc. (NASDAQ: SCYX) today announced that the Company will present at the 15th Annual Needham Healthcare Conference at The Westin Grand Central Hotel in New York City on Wednesday, April 13, 2016 at 12:10 p.m. ET.

A live webcast will be available on the investors section of the Company's website: www.scynexis.com. A replay of the presentation will be available approximately two hours after the event and will be available for two weeks following the presentation.

About SCYNEXISSCYNEXIS is a pharmaceutical company committed to the development and commercialization of novel anti-infectives to address significant unmet therapeutic needs. We are developing our lead product candidate, SCY-078, as an oral and IV drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. For more information, visit www.scynexis.com. 

CONTACT:

Media Relations
Heather Savelle
MacDougall Biomedical Communications
Tel: 781.235.3060
[email protected]

Investor Relations
Susan Kim
Argot Partners
Tel: 212-203-4433
[email protected]

You May Also Be Interested In

• SCYNEXIS (SCYX) PT Raised to $33 at Guggenheim
• Sunny Creek Modulars Expands Turnkey Accessory Dwelling Unit Solutions to Meet Growing Regional Housing Demand
• Dr. Christina Rahm Named Gold Stevie® Winner for Woman of the Year in Innovation